A Pharmahungary 2000 Kft., a Pharmahungary Group tagjának küldetése saját fejlesztésű

kutatás fejlesztési innovációs (KFI) projektek piacra vitele és innovatív preklinikai és klinikai KFI szolgáltatások

THE GENERAL ASSEMBLY OF THE HUNGARIAN BIOTECHNOLOGY ASSOCIATION ELECTS ITS NEW BOARD

Proud to share that VRG Therapeutics is entering a co-development partnership and option agreement with AOP Health to advance a new immunology program.
This collaboration brings together our AI-driven miniprotein discovery platform with AOP Health’s clinical development expertise, with the shared goal of accelerating a novel immune cell activity regulator toward first-in-human studies for autoimmune and inflammatory diseases.
Excited for what’s ahead!

Our team attended the Swiss Biotech Day - great connections and inspiring discussions throughout the event.

It also provided valuable inspiration for the renewing Hungarian Biotechnology Association. 🌱

Hopefully, we’ll see HBA represented in the Global Village next year and maybe, in a few years, we’ll be hosting a similar event in Hungary.

Thanks to the Swiss Biotech Association for the excellent organization.

Another proud moment for the Hungarian biotech 🚀

Big news from one of our members: Turbine has closed a $25M Series B round, led by Interactive Venture Partners with participation from Beiersdorf Venture Capital.